[A11-04] Olmesartan/amlodipine/HCT (combination of active ingredients) - benefit assessment acc. to §35a Social Code Book V (dossier assessment)
Last updated 23.11.2011
Project no.:
A11-04
Commission:
Commission awarded on 21.02.2011 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Heart and circulation
Note:
The commission on a benefit assessment according to §35a SGB V has become irrelevant. You can find more information on thewebsite of the Federal Joint Committee (G-BA).
| Project no. | Title | Status |
|---|---|---|
| A11-03 | Olmesartan/amlodipine/HCT (combination of active ingredients) - consultation on the content and completeness of the dossier | Commission completed |